Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Precipio, Inc. (PRPO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0100-0.0200 (-0.99%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.0300
Open2.0300
Bid2.0000 x 2200
Ask2.0100 x 800
Day's Range1.9800 - 2.4400
52 Week Range1.7200 - 9.1800
Volume1,316,784
Avg. Volume274,963
Market Cap36.448M
Beta (5Y Monthly)2.64
PE Ratio (TTM)N/A
EPS (TTM)-0.8480
Earnings DateNov 17, 2021 - Nov 22, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
  • GlobeNewswire

    New York State Approves Precipio’s HemeScreen for POL clinical use

    New York Cancer & Blood POL will commence the use of HemeScreen in its laboratoryNEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from New York State’s Department of Health (NY DOH). Hemescreen can now be used by New York based physician-owned laboratories (POLs) who apply to run HemeScreen in their lab as a laboratory-developed test (LDT). New York Sta

  • GlobeNewswire

    89bio Announces Appointment of Kathy LaPorte to its Board of Directors

    SAN FRANCISCO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the appointment of Kathy LaPorte to its Board of Directors, effective immediately. Ms. LaPorte brings deep expertise and valuable experience in the industry to the Company. "It is a pleasure to welcome Kathy, an esteemed industry lea

  • GlobeNewswire

    Precipio Announces Q3-2021 and year-end Shareholder Update Call

    Conference Call to be held on Monday, November 15th, 2021 at 5:00 PM ESTNEW HAVEN, Conn., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2021 update call on Monday, November 15th at 5:00 PM ET. The call will include updates on the company’s current core businesses. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. confer

Advertisement
Advertisement